Cognitive Behavior Therapy for tinnitus related insomnia: a single-case experiment

Maastricht University Faculty of Psychology and Neuroscience0 个研究点目标入组 6 人开始时间: 待定最近更新: 2024年2月28日

试验速览

暂无简介。

•In order to be eligible to participate in this study, a subject must meet all of the following criteria:
•- Be primarily seeking treatment/help for difficulties caused by tinnitus.
•- Additionally complaints of sleep disturbance (e.g. insomnia) as measured by the Insomnia Severity Index.
•- Recommended to start CBTi protocol.
•- Be at least 18 years of age. - Have at least moderate tinnitus (as defined by the Tinnitus Questionnaire)

•- Any person who discloses current suicidal intent.
•- Severe anxiety or depression (as measured by the HADS-A and/or HADS-D.)
•- Pregnancy of potential participant or partner.
•- Currently undergoing any treatment for tinnitus (e.g. Tinnitus Retraining Therapy).
•- Reported to have commenced or ceased a course of antidepressants [i.e. selective serotonin re-uptake inhibitors (SSRIs); selective serotonin and norepinephrine re-uptake inhibitors (SNRIs); atypical antidepressants, tricyclic antidepressants, or monoamine oxidase inhibitors], antipsychotics [Aripiprazole (Abilify), Asenapine (Saphris), Brexpiprazole (Rexulti), Cariprazine (Vraylar), Clozapine (Clozaril), Iloperidone (Fanapt), Lurasidone (Latuda), Olanzapine (Zyprexa), Paliperidone (Invega), Quetiapine (Seroquel), Risperidone (Risperdal), Ziprasidone (Geodon), Haloperidol], anxioltytics [beta blockers, benzodiazepines], Ritalin, hormone replacement therapy, or medication to lower high blood pressure (i.e. thiazide diuretics, ACE inhibitors, angiotensin II receptor blockers, beta blockers, calcium channel blockers, renin inhibitors] within the previous 3 months
•- Unable to read and write fluently in Dutch.

发起方

Maastricht University Faculty of Psychology and Neuroscience